Zur Kurzanzeige

2023-05-04Zeitschriftenartikel
Lessons from COVID-19 for rescalable data collection
dc.contributor.authorBhatia, Sangeeta
dc.contributor.authorImai, Natsuko
dc.contributor.authorWatson, Oliver J.
dc.contributor.authorAbbood, Auss
dc.contributor.authorAbdelmalik, Philip
dc.contributor.authorCornelissen, Thijs
dc.contributor.authorGhozzi, Stéphane
dc.contributor.authorLassmann, Britta
dc.contributor.authorNagesh, Radhika
dc.contributor.authorRagonnet-Cronin, Manon L.
dc.contributor.authorSchnitzler, Johannes Christof
dc.contributor.authorKraemer, Moritz U. G.
dc.contributor.authorChauchemez, Simon
dc.contributor.authorNouvellet, Pierre
dc.contributor.authorCori, Anne
dc.date.accessioned2026-01-23T09:51:46Z
dc.date.available2026-01-23T09:51:46Z
dc.date.issued2023-05-04none
dc.identifier.other10.1016/S1473-3099(23)00121-4
dc.identifier.urihttp://edoc.rki.de/176904/13191
dc.description.abstractNovel data and analyses have had an important role in informing the public health response to the COVID-19 pandemic. Existing surveillance systems were scaled up, and in some instances new systems were developed to meet the challenges posed by the magnitude of the pandemic. We describe the routine and novel data that were used to address urgent public health questions during the pandemic, underscore the challenges in sustainability and equity in data generation, and highlight key lessons learnt for designing scalable data collection systems to support decision making during a public health crisis. As countries emerge from the acute phase of the pandemic, COVID-19 surveillance systems are being scaled down. However, SARS-CoV-2 resurgence remains a threat to global health security; therefore, a minimal cost-effective system needs to remain active that can be rapidly scaled up if necessary. We propose that a retrospective evaluation to identify the cost-benefit profile of the various data streams collected during the pandemic should be on the scientific research agenda.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subjectCOVID-19* / epidemiologyeng
dc.subjectData Collectioneng
dc.subjectHumanseng
dc.subjectPandemics / prevention & controleng
dc.subjectRetrospective Studieseng
dc.subjectSARS-CoV-2eng
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleLessons from COVID-19 for rescalable data collectionnone
dc.typearticle
dc.identifier.urnurn:nbn:de:0257-176904/13191-8
dc.type.versionpublishedVersionnone
local.edoc.container-titleThe Lancet Infectious Diseasesnone
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-publisher-nameElsevier B.V.none
local.edoc.container-reportyear2023none
local.edoc.container-firstpagee383none
local.edoc.container-lastpagee388none
dc.description.versionPeer Reviewednone

Zur Kurzanzeige